M&A bankers looking for the nearest ledge to jump off should turn to drugs to relieve their pain. A pharmaceutical deal in the next few months could offer a needed high to depressed M&A volumes. There are whispers of encouragement from arbitrageurs, with bets placed on a takeover of Bayer by Pfizer or a bid by Sanofi for Bristol-Myers Squibb.
No comments:
Post a Comment